Nevisense Go, a portable, non-invasive tool that uses electrical impedance spectroscopy measurements for skin barrier assessment, will be studied in clinical practice at hospitals in Switzerland.
WHY IT MATTERS
With 20% of children developing atopic dermatitis, SciBase, developer of the AI…
Source: Healthcareitnews.com and Read More
Wall Street’s Leaders and Laggards of 2024
2024 was a mixed year for biopharma stocks, with the iShares Biotechnology ETF and SPDR S&P Biotech ETF experiencing small decreases. Federal Reserve decisions caused
